Annual CFI
-$773.31 M
-$847.90 M-1136.82%
December 31, 2023
Summary
- As of February 24, 2025, PCVX annual cash flow from investing activities is -$773.31 million, with the most recent change of -$847.90 million (-1136.82%) on December 31, 2023.
- During the last 3 years, PCVX annual CFI has fallen by -$772.21 million (-69882.90%).
- PCVX annual CFI is now -1136.82% below its all-time high of $74.58 million, reached on December 31, 2022.
Performance
PCVX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
-$917.02 M
-$836.61 M-1040.49%
September 30, 2024
Summary
- As of February 24, 2025, PCVX quarterly cash flow from investing activities is -$917.02 million, with the most recent change of -$836.61 million (-1040.49%) on September 30, 2024.
- Over the past year, PCVX quarterly CFI has stayed the same.
- PCVX quarterly CFI is now -1946.37% below its all-time high of $49.67 million, reached on March 31, 2022.
Performance
PCVX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$1.46 B
-$939.30 M-179.56%
September 30, 2024
Summary
- As of February 24, 2025, PCVX TTM cash flow from investing activities is -$1.46 billion, with the most recent change of -$939.30 million (-179.56%) on September 30, 2024.
- Over the past year, PCVX TTM CFI has stayed the same.
- PCVX TTM CFI is now -1422.04% below its all-time high of $110.62 million, reached on September 30, 2022.
Performance
PCVX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
PCVX Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1136.8% | 0.0% | 0.0% |
| 3 y3 years | -10000.0% | 0.0% | 0.0% |
| 5 y5 years | -10000.0% | 0.0% | 0.0% |
PCVX Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -1136.8% | at low | -1946.4% | at low | -1422.0% | at low |
| 5 y | 5-year | -1136.8% | at low | -1946.4% | at low | -1422.0% | at low |
| alltime | all time | -1136.8% | at low | -1946.4% | at low | -1422.0% | at low |
Vaxcyte Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$917.02 M(+1040.5%) | -$1.46 B(+179.6%) |
| Jun 2024 | - | -$80.41 M(-82.2%) | -$523.13 M(-32.6%) |
| Mar 2024 | - | -$451.07 M(+3139.1%) | -$776.28 M(+0.4%) |
| Dec 2023 | -$773.31 M(-1136.8%) | -$13.93 M(-162.5%) | -$773.31 M(-2.8%) |
| Sep 2023 | - | $22.28 M(-106.7%) | -$795.34 M(+1.6%) |
| Jun 2023 | - | -$333.56 M(-25.6%) | -$782.91 M(+85.0%) |
| Mar 2023 | - | -$448.10 M(+1146.4%) | -$423.18 M(-667.4%) |
| Dec 2022 | $74.58 M(-135.1%) | -$35.95 M(-203.6%) | $74.58 M(-32.6%) |
| Sep 2022 | - | $34.71 M(+32.6%) | $110.62 M(+92.6%) |
| Jun 2022 | - | $26.16 M(-47.3%) | $57.44 M(+434.4%) |
| Mar 2022 | - | $49.67 M(>+9900.0%) | $10.75 M(-105.1%) |
| Dec 2021 | -$212.31 M | $82.00 K(-100.4%) | -$212.31 M(-0.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$18.47 M(-10.0%) | -$213.11 M(+9.5%) |
| Jun 2021 | - | -$20.53 M(-88.2%) | -$194.62 M(+11.8%) |
| Mar 2021 | - | -$173.39 M(>+9900.0%) | -$174.15 M(>+9900.0%) |
| Dec 2020 | -$1.10 M(-7.5%) | -$722.00 K(-3538.1%) | -$1.10 M(-17.3%) |
| Sep 2020 | - | $21.00 K(-138.2%) | -$1.34 M(-5.7%) |
| Jun 2020 | - | -$55.00 K(-84.2%) | -$1.42 M(-7.3%) |
| Mar 2020 | - | -$349.00 K(-63.4%) | -$1.53 M(+27.9%) |
| Dec 2019 | -$1.20 M(-32.6%) | -$953.00 K(+1488.3%) | -$1.20 M(+393.8%) |
| Sep 2019 | - | -$60.00 K(-63.9%) | -$242.00 K(+33.0%) |
| Jun 2019 | - | -$166.00 K(+937.5%) | -$182.00 K(+1037.5%) |
| Mar 2019 | - | -$16.00 K | -$16.00 K |
| Dec 2018 | -$1.77 M | - | - |
FAQ
- What is Vaxcyte annual cash flow from investing activities?
- What is the all time high annual CFI for Vaxcyte?
- What is Vaxcyte annual CFI year-on-year change?
- What is Vaxcyte quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Vaxcyte?
- What is Vaxcyte quarterly CFI year-on-year change?
- What is Vaxcyte TTM cash flow from investing activities?
- What is the all time high TTM CFI for Vaxcyte?
- What is Vaxcyte TTM CFI year-on-year change?
What is Vaxcyte annual cash flow from investing activities?
The current annual CFI of PCVX is -$773.31 M
What is the all time high annual CFI for Vaxcyte?
Vaxcyte all-time high annual cash flow from investing activities is $74.58 M
What is Vaxcyte annual CFI year-on-year change?
Over the past year, PCVX annual cash flow from investing activities has changed by -$847.90 M (-1136.82%)
What is Vaxcyte quarterly cash flow from investing activities?
The current quarterly CFI of PCVX is -$917.02 M
What is the all time high quarterly CFI for Vaxcyte?
Vaxcyte all-time high quarterly cash flow from investing activities is $49.67 M
What is Vaxcyte quarterly CFI year-on-year change?
Over the past year, PCVX quarterly cash flow from investing activities has changed by $0.00 (0.00%)
What is Vaxcyte TTM cash flow from investing activities?
The current TTM CFI of PCVX is -$1.46 B
What is the all time high TTM CFI for Vaxcyte?
Vaxcyte all-time high TTM cash flow from investing activities is $110.62 M
What is Vaxcyte TTM CFI year-on-year change?
Over the past year, PCVX TTM cash flow from investing activities has changed by $0.00 (0.00%)